-
June 19, 2021 Atai Life Sciences Valued At More Than $3 Billion After IPOGerman psychedelic pharmaceutical company Atai Life Sciences is valued at more than $3 billion after...
-
June 19, 2021 27 Publicly-Traded Psychedelic Stocks Investors Have Their Eyes OnThese psychedelic stocks are all publicly trading. Take a look at the companies leading the...
-
June 14, 2021 Peter Thiel-Backed Atai Life Sciences Announces IPO With $2 Billion ValuationAtai Life Sciences is the latest psychedelic company to announce plans to IPO. The Peter...
-
June 8, 2021 Field Trip Health Begins Trading on TSE, Sets Sights on NasdaqPsychedelic lifestyle brand Field Trip Health is now trading on the Toronto Stock Exchange under...
-
May 27, 2021 Psychedelic Platform Field Trip Health Gets Uplisting Conditional Approval for Toronto Stock ExchangePsychedelic healing platform Field Trip Health has received conditional approval to uplist to the Toronto...
-
May 26, 2021 Psychedelic Drug Development Company Mynd Life Sciences Goes Public on the CSEPsychedelic drug development company Mynd Life Sciences has gone public on the CSE.
-
May 10, 2021 Psychedelic Investment Platform Clarify Pharma to Go Public With £10.5 Million ValuationThe psychedelic investment platform Clarify Pharma is expecting to go public on the AQSE with...
